The pharmaceutical industry has been slow to adopt a business practice that is faster, safer, and more efficient than its current way of operating; that the FDA has been encouraging the industry to implement more widely for years; and that has been used effectively in other industries for decades. I’m talking about continuous manufacturing.
Continuous manufacturing produces a drug product from start to finish through a nonstop, integrated assembly. In contrast, most of the pharmaceutical industry currently uses batch manufacturing, which involves producing a finished drug product through multiple distinct steps in series.
As a pioneer in the continuous manufacturing of pharmaceuticals, I continue to be surprised by the slow pace at which pharma has embraced this innovation.
Create a display name to comment
This name will appear with your comment
